Breaking News Instant updates and real-time market news.

RYI

Ryerson

$5.30 /

-0.07 (-1.30%)

20:05
07/13/20
07/13
20:05
07/13/20
20:05

Ryerson sees Q2 revenue $765M-$775M, consensus $761.4M.

Sees Q2 adj. EBITDA $19M-$21M and net loss of $26M to $28M. The company states: "Early indications for Q3 are seeing a continuation of the recovery initiated in Q2 as average selling prices, gross margins, excluding LIFO and order rates are all currently trending positively. "

RYI Ryerson
$5.30 /

-0.07 (-1.30%)

05/20/20 BMO Capital
Ryerson price target lowered to $6 from $9 at BMO Capital
08/26/19 BMO Capital
Ryerson price target lowered to $7 from $9 at BMO Capital

TODAY'S FREE FLY STORIES

Recommendations
Moderna COVID vaccine price per dose lower than expected, says JPMorgan » 05:18
08/13/20
08/13
05:18
08/13/20
05:18
MRNA

Moderna

$69.60 /

+0.66 (+0.96%)

JPMorgan analyst Cory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$69.60 /

+0.66 (+0.96%)

MRNA Moderna
$69.60 /

+0.66 (+0.96%)

08/11/20 Piper Sandler
Government awards for Moderna validates vaccine promise, says Piper Sandler
08/06/20 Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
MRNA Moderna
$69.60 /

+0.66 (+0.96%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$69.60 /

+0.66 (+0.96%)

MRNA Moderna
$69.60 /

+0.66 (+0.96%)

MRNA Moderna
$69.60 /

+0.66 (+0.96%)

Hot Stocks
Genentech: FDA accepts sBLA for self-administration option for Xolair » 05:18
08/13/20
08/13
05:18
08/13/20
05:18
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Federal Bank chooses Fiserv to support first independent credit card launch » 05:14
08/13/20
08/13
05:14
08/13/20
05:14
FISV

Fiserv

$97.95 /

-0.23 (-0.23%)

Fiserv said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FISV Fiserv
$97.95 /

-0.23 (-0.23%)

FISV Fiserv
$97.95 /

-0.23 (-0.23%)

08/11/20 Morgan Stanley
Fiserv price target raised to $96 from $90 at Morgan Stanley
07/22/20 Barclays
Fiserv shares undervalued after 'clearing event,' says Barclays
07/14/20 Barclays
Fiserv pullback brings 'unique buying opportunity,' says Barclays
07/14/20 Goldman Sachs
Fiserv initiated with a Conviction Buy at Goldman Sachs
FISV Fiserv
$97.95 /

-0.23 (-0.23%)

FISV Fiserv
$97.95 /

-0.23 (-0.23%)

FISV Fiserv
$97.95 /

-0.23 (-0.23%)

General news
IEA cuts forecasts for global oil demand » 05:10
08/13/20
08/13
05:10
08/13/20
05:10

IEA cuts forecasts for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Week of 8/7 EIA Natural Gas Report to be released at 10:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
6-Month Bill Announcement to be released at 11:00  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
8-Week Bill Auction to be released at 11:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
4-Week Bill Auction to be released at 11:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
Week of 8/3 Money Supply to be released at 16:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
General news
Week of 8/12 Fed Balance Sheet to be released at 16:30  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
Conference/Events
Seaport Global forest products analyst to hold analyst/industry conference call » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Analysts, along with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Aerie Pharmaceuticals management to meet virtually with Needham » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
AERI

Aerie Pharmaceuticals

$12.37 /

+0.12 (+0.98%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

08/07/20 Mizuho
Aerie Pharmaceuticals price target lowered to $27 from $29 at Mizuho
08/07/20 Piper Sandler
Aerie Pharmaceuticals price target lowered to $25 from $35 at Piper Sandler
06/01/20 Oppenheimer
Aerie Pharmaceuticals assumed with an Outperform at Oppenheimer
05/07/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $31 from $37 at H.C. Wainwright
AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

AERI Aerie Pharmaceuticals
$12.37 /

+0.12 (+0.98%)

Conference/Events
Needham to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Virtual Digital Commerce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Maxim Group and M-Vest to co-host a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
AGRX

Agile Therapeutics

$2.41 /

-0.185 (-7.14%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DARE

Dare Bioscience

$1.18 /

-0.015 (-1.26%)

Leading Innovators in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DARE Dare Bioscience
$1.18 /

-0.015 (-1.26%)

AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

03/20/20 H.C. Wainwright
H.C. Wainwright 'strongly' reiterates Buy on Agile Therapeutics
02/19/20 Janney Montgomery Scott
Agile Therapeutics price target raised to $9 from $4 at Janney Montgomery Scott
02/18/20 H.C. Wainwright
Agile Therapeutics price target raised to $7 from $5 at H.C. Wainwright
02/18/20 RBC Capital
Agile Therapeutics price target raised to $8 from $5 at RBC Capital
BAYRY Bayer
$0.00 /

+ (+0.00%)

08/11/20 Deutsche Bank
Bayer price target lowered to EUR 82 from EUR 87 at Deutsche Bank
08/11/20 Berenberg
Bayer price target lowered to EUR 76 from EUR 86 at Berenberg
08/10/20 Morgan Stanley
Bayer price target lowered to EUR 83 from EUR 88 at Morgan Stanley
06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
DARE Dare Bioscience
$1.18 /

-0.015 (-1.26%)

04/27/20 Brookline
Dare Bioscience initiated with a Buy at Brookline
03/31/20 Roth Capital
Dare Bioscience price target lowered to $4 from $6 at Roth Capital
08/22/19 Aegis
Dare Bioscience initiated with a Buy at Aegis
AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DARE Dare Bioscience
$1.18 /

-0.015 (-1.26%)

  • 21
    Feb
BAYRY Bayer
$0.00 /

+ (+0.00%)

AGRX Agile Therapeutics
$2.41 /

-0.185 (-7.14%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

General news
3-Month Bill Announcement to be released at 11:00  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 
Conference/Events
CNS Pharmaceuticals to hold a webinar » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
CNSP

CNS Pharmaceuticals

$1.76 /

-0.09 (-4.86%)

CEO Climaco discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNSP CNS Pharmaceuticals
$1.76 /

-0.09 (-4.86%)

CNSP CNS Pharmaceuticals
$1.76 /

-0.09 (-4.86%)

12/04/19 Benchmark
CNS Pharmaceuticals initiated with a Speculative Buy at Benchmark
  • 08
    Nov
Conference/Events
Raymond James to hold a virtual summit » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Aspen Energy Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
William Blair to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

3rd Annual Insurance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Jobless Claims to be reported at 08:30 » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Week of 8/8 Jobless…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Cantor Fitzgerald security analysts hold an analyst/industry conference call » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Analysts provide a summer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
HNI Corporation management to meet virtually with Benchmark » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
HNI

HNI Corporation

$32.23 /

+0.05 (+0.16%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HNI HNI Corporation
$32.23 /

+0.05 (+0.16%)

HNI HNI Corporation
$32.23 /

+0.05 (+0.16%)

05/22/20 Benchmark
HNI Corporation initiated with a Buy at Benchmark
HNI HNI Corporation
$32.23 /

+0.05 (+0.16%)

Conference/Events
FDA Oncologic Drugs Advisory Committee to hold a virtual meeting » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
MESO

Mesoblast

$11.80 /

+0.42 (+3.69%)

The Committee discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
05/28/20 Ladenburg
Mesoblast price target raised to $15.25 from $13 at Ladenburg
05/28/20 H.C. Wainwright
Mesoblast price target raised to $21 from $14 at H.C. Wainwright
04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

MESO Mesoblast
$11.80 /

+0.42 (+3.69%)

Conference/Events
Needham to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55

Virtual Semi-Cap &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Wedbush to hold a virtual summit » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
SHOO

Steven Madden

$22.83 /

-0.16 (-0.70%)

, SKX

Skechers

$30.35 /

-0.38 (-1.24%)

, WWW

Wolverine World Wide

$25.16 /

+0.15 (+0.60%)

2020 Virtual Footwear…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHOO Steven Madden
$22.83 /

-0.16 (-0.70%)

SKX Skechers
$30.35 /

-0.38 (-1.24%)

WWW Wolverine World Wide
$25.16 /

+0.15 (+0.60%)

SHOO Steven Madden
$22.83 /

-0.16 (-0.70%)

07/30/20 B. Riley FBR
Steven Madden price target lowered to $29 from $34 at B. Riley FBR
07/22/20 UBS
Steven Madden initiated with a Neutral at UBS
05/14/20
Fly Intel: Top five analyst downgrades
05/14/20 Wells Fargo
Wells Fargo downgrades Steven Madden to Underweight on brand weakness
SKX Skechers
$30.35 /

-0.38 (-1.24%)

07/24/20 B. Riley FBR
Skechers price target raised to $39 from $37 at B. Riley FBR
07/24/20 Deutsche Bank
Skechers price target raised to $39 from $34 at Deutsche Bank
07/14/20 Deutsche Bank
Skechers price target raised to $34 from $30 at Deutsche Bank
07/10/20 Susquehanna
Skechers price target raised to $39 from $32 at Susquehanna
WWW Wolverine World Wide
$25.16 /

+0.15 (+0.60%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Pivotal Research
Wolverine World Wide upgraded to Buy from Hold at Pivotal Research
06/10/20 Wedbush
Wolverine World Wide price target raised to $31 from $24 at Wedbush
05/22/20 B. Riley FBR
B. Riley FBR starts Wolverine World Wide with Buy, sees over 30% upside
SHOO Steven Madden
$22.83 /

-0.16 (-0.70%)

SKX Skechers
$30.35 /

-0.38 (-1.24%)

WWW Wolverine World Wide
$25.16 /

+0.15 (+0.60%)

SKX Skechers
$30.35 /

-0.38 (-1.24%)

SKX Skechers
$30.35 /

-0.38 (-1.24%)

General news
Atlanta Federal Reserve Bank President Raphael Bostic Speech to be released at 11:00  04:55
08/13/20
08/13
04:55
08/13/20
04:55
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.